Monogram Orthopaedics Inc... (MGRM)
Bid | 2.63 |
Market Cap | 94.93M |
Revenue (ttm) | n/a |
Net Income (ttm) | -16.33M |
EPS (ttm) | -0.51 |
PE Ratio (ttm) | -5.27 |
Forward PE | -6.72 |
Analyst | Strong Buy |
Ask | 2.67 |
Volume | 49,416 |
Avg. Volume (20D) | 670,862 |
Open | 2.71 |
Previous Close | 2.67 |
Day's Range | 2.68 - 2.80 |
52-Week Range | 1.84 - 4.21 |
Beta | 0.73 |
About MGRM
undefined
Analyst Forecast
According to 0 analyst ratings, the average rating for MGRM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts
1 month ago · accessnewswire.com
Monogram Technologies Announces FDA 510(k) Clearance for the Monogram mBôsTM TKA SystemMonogram May Market the Monogram mBôs™ TKA System, Subject to the Requirements of the Federal Food, Drug, and Cosmetic Act (the Act). The Company is Preparing for Commercialization and Evaluating Stra...

1 month ago · seekingalpha.com
Monogram Technologies Inc. (MGRM) Q4 2024 Earnings Call TranscriptMonogram Technologies Inc. (NASDAQ:MGRM ) Q4 2024 Earnings Conference Call March 11, 2025 4:30 PM ET Company Participants Larry Holub - Investor Relations Benjamin Sexson - Chief Executive Officer Noe...

1 month ago · accessnewswire.com
CORRECTION: Monogram Technologies Reports Full Year 2024 Financial ResultsThis Press Release is Acting as a Correction to the Financial Tables in the Previous Release Completed all Supplemental Testing and has Submitted its Formal Response to the FDA's Additional Informatio...